Houston Doctor's Lawsuit Forces FDA to Remove COVID-19-Related Ivermectin Posts | 22 March 2024 | The U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) have agreed to remove social media posts and an online article that warned against off-label use of ivermectin to treat COVID-19, according to an agreement entered in a federal court Thursday. Dr. Mary Talley Bowden, a Houston-based Ear, Nose, and Throat specialist, was one of three doctors who filed suit against the federal agency in 2022 alleging that FDA statements were interfering with their ability to treat patients. "After nearly two years and a resounding rebuke by the Fifth Circuit Court of Appeals, the FDA has agreed to remove its misleading social media posts and consumer directives regarding ivermectin and COVID-19," Bowden said in a statement to The Texan.

Subscribe to CLG newsletter

Subscribe to newsletter

Subscribe to the CLG newsletter. (We don't sell or share data.) Enter your email address below!